Understanding how certain immune cells contribute to multiple sclerosis
A TCF1:Glucocorticoid regulatory circuit controls IL-23-driven Th17 pathogenicity
This study is looking at how certain immune cells called Th17 cells can change and cause inflammation in multiple sclerosis, with the hope of finding new ways to treat the condition and help patients feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11011462 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, known as Th17 cells, in the development of multiple sclerosis (MS). It focuses on understanding how these cells can switch from a non-pathogenic state to a pathogenic state that drives inflammation in the central nervous system. By studying genetic factors and signaling pathways involved in this process, the research aims to uncover new therapeutic targets for MS treatment. Patients may benefit from insights that could lead to innovative therapies aimed at preventing or reducing the severity of MS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis or those at risk due to genetic factors.
Not a fit: Patients with other autoimmune conditions unrelated to Th17 cell activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better manage or prevent multiple sclerosis.
How similar studies have performed: Previous research has shown promising results in understanding Th17 cell biology, suggesting that this approach could yield valuable insights for MS treatment.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Anderson, Ana C — Brigham and Women's Hospital
- Study coordinator: Anderson, Ana C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.